Nitric oxide and inflammatory bowel diseases

European Journal of Clinical Investigation

Volumn 28, Issue 11, 1998, Pages 904-907

  Guslandi, M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SALICYLIC ACID DERIVATIVE; STEROID;

COLON DILATATION; CROHN DISEASE; ENTERITIS; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; PRIORITY JOURNAL; SHORT SURVEY; TOXIC MEGACOLON; ULCERATIVE COLITIS;

ANIMALS; COLITIS, ULCERATIVE; CROHN DISEASE; ENZYME INHIBITORS; HUMANS; INFLAMMATORY BOWEL DISEASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III;

EID: 0031761195     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00377.x     Document Type: Short Survey

References (42)

1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
2. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-64.
3. Beckman JS, Koppenol WH. Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly. Am J Physiol 1996; 271: C1424-37.
4. Kennedy M, Denenberg AG, Szabo C, Salzman AL. Poly(ADB-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells. Gastroenterology 1998; 114: 510-8.
5. Colgan SP. Nitric oxide and intestinal epithelia: just say NO. Gastroenterology 1998; 114: 601-3.
6. Munkholm P, Langholz E, Hollander D et al. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut 1994; 35: 68-72.
7. Kimura H, Hokari R, Miura S et al. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 1998; 42: 180-7.
8. Guslandi M. Nitric oxide: an ubiquitous actor in the gastroin-testinal tract. Dig Dis 1994; 12: 28-36.
9. Middleton SJ, Shorthouse M, Hunter JO. Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993; 341: 465-6.
10. Ribbons KA, Zhang X-J, Thompson JH et al. Potential role of nitric oxide in a model of chronic colitis in Rhesus macaques. Gastroenterology 1995; 108: 705-11.
11. Rachmilewitz D, Stamler JS, Bachwich D, Karrmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995; 36: 718-23.
12. Roediger WEW, Lawson MJ, Nance SH, Radcliffe BC. Detectable colonic nitrite levels in inflammatory bowel disease - mucosal or bacterial malfunction? Digestion 1986; 35: 199-204.
13. Oudkerk-Pool M, Bouma G, Visser JJ et al. Serum nitrate levels in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 1995; 30: 784-8.
14. Rees DC, Satsangi J, Cornelissen PL, Travis SP, White J, Jewell DP. Are serum concentrations of nitric oxide metabolites useful for predicting the clinical outcome of ulcerative colitis? Eur J Gastroenterol Hepatol 1995; 7: 227-30.
15. Levine JJ, Pettei MJ, Valderrama E, Gold DM, Kessler BH, Trachtman H. Nitric oxide sand inflammatory bowel disease: evidence for local intestinal production in children with active colonic disease. J Ped Gastroenterol Nutr 1998; 26: 34-8.
16. Lundberg JON, Hellstrom PM, Lundberg JM, Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994; 344: 1673-4.
17. Reynolds PD, Middleton SJ, Hansford GM, Hunter JO. Confirmation of nitric oxide synthesis in active ulcerative colitis by infra-red diode laser spectroscopy. Eur J Gastroenterol Hepatol 1997; 9: 463-6.
18. Herulf M, Ljung T, Hellstrom PM, Weitzberg E, Lundberg JON. Increased luminal nitric oxide in inflammatory bowel disease as shown with a novel minimally invasive method. Scand J Gastroenterol 1998; 33: 164-9.
19. Boughton-Smith NK, Evans SM, Hawkey CJ et al. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993; 342: 338-40.
20. Godkin AJ, De Belder AJ, Villa L et al. Expression of nitric oxide synthase in ulcerative colitis. Eur J Clin Invest 1996; 26: 867-72.
21. Singer II, Kawka DW, Scott S et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996; 111: 871-85.
22. Ikeda I, Kasajima T, Ishyama S et al. Distribution of inducible nitric oxide synthase in ulcerative colitis. Am J Gastroenterol 1997; 92: 1339-41.
23. Kroesen AJ, Schonfelder JM, Runkel N, Wiedenmann B, Buhr HJ. Expression of inducible nitric oxide synthase in pouchitis after ileoanal pouch surgery for ulcerative colitis. Langenbecks Arch Chir 1997; 114 (Suppl.): 451-4.
24. Tamai H, Gaginella TS. Direct evidence for nitric oxide stimulation of electrolyte secretion in the rat colon. Free Radic Res Commun 1993; 19: 1229-39.
25. Boughton-Smith NK, Evans SM, Whittle BRJ. Characterization of nitric oxide synthase activity in the rat colonic mucosa and muscle after endotoxin and in a model of colitis. Agents Actions 1994; 41: 223-5.
26. Ferretti M, Gionchetti P, Rizzello F et al. Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis. Dig Dis Sci 1997; 42: 2606-11.
27. McCafferty DM, Mudgett JS, Swain MG, Kubes P. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 1997; 112: 1022-7.
28. Mourelle M, Casellas F, Guarner F et al. Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterology 1995; 109: 1497-502.
29. Geboes K, Mebis J, Rutgeers P, Ectors N, Vantrappen G. Demonstration of nitric oxide positive neurons in Crohn's disease. Gastroenterology 1993; 104: A705.
30. Kimura H, Miura S, Shigematsu T et al. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci 1997; 42: 1047-54.
31. Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression of an inducible but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 1043-7.
32. Conde M, Andrade J. Inhibitory effect of cyclosporin A and FK 506 on nitric oxide production by cultured macrophages. Evidence for a direct effect on nitric oxide synthase activity. Immunology 1995; 84: 476-81.
33. Pallapies D, Peskar BA, Peskar BM. 5-aminosalicylic acid (5-ASA) inhibits the activity of nitric oxide: contribution to its anti-inflammatory effects. Gastroenterology 1992; 102: A677.
34. Reynolds PD, Middleton SJ, Shorthouse M, Hunter JO. The effect of aminosalicylic acid derivatives on nitric oxide in a cell-free system. Aliment Pharmacol Ther 1995; 9: 491-5.
35. Hogaboam CM, Jacobson K, Collins SM. The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am J Physiol 1995; 268: G673-84.
36. Rachmilewitz D, Karmeli F, Okon E, Burstzyn M. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 1995; 32: 247-55.
37. Seago ND, Thompson JH, Zhang XJ et al. Inducible nitric oxide synthase and guinea pig ileitis by adjuvant. Med Inflam 1995; 4: 19-24.
38. Pfeiffer CJ, Qiu BS. Effects of chronic nitric oxide synthase inhibition TBN-induced colitis in rats. J Pharm Pharmacol 1995; 47: 827-32.
39. Dobosz M, Mionskowska L, Dobrowolski S. Is nitric oxide and heparin treatment justified in inflammatory bowel disease? An experimental study. Scand J Clin Lab Invest 1996; 56: 657-63.
40. Miller MJS, Xhang XJ, Sadowska-Krowicka H et al. Nitric oxide release in response to gut injury. Scand J Gastroenterol 1993; 28: 149-54.
41. Ribbons KA, Currie MG, Connor JR et al. The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey. J Pharmacol Exp Therap 1997; 280: 1008-15.
42. Szabo C, Lim LH, Cuzzocrea S et al. Inhibition of poly (ADP-ribose) synthetase exerts anti-inflammatory effects and inhibits neutrophil recruitment. J Exp Med 1997; 186: 1041-9.